Ligand activation of PPARβ/δ resulted in a significant decrease in RPE lipid accumulation (Figure 2I), suggesting a potential therapeutic avenue to pursue in the treatment of early dry AMD, in which removal of extra- and intra-cellular lipids is a goal. The gene discussed is PPARD; the disease is dry age related macular degeneration.